NASDAQ: SLSNSolesence Inc Stock
$0.86+0.01 (+1.18%)
Updated Nov 2, 2026
SLSN Price
$0.86
Fair Value Price
N/A
Market Cap
$60.47M
52 Week Low
$0.61
52 Week High
$3.40
P/E
-42.8x
P/B
4.6x
P/S
0.94x
PEG
N/A
Dividend Yield
N/A
Revenue
$55.37M
Earnings
-$1.88M
Gross Margin
26.9%
Operating Margin
-1.79%
Profit Margin
-3.4%
Debt to Equity
2.53
Operating Cash Flow
$1M
Beta
0.75
Next Earnings
Nov 10, 2026
Ex-Dividend
N/A
Next Dividend
N/A
SLSN Overview
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SLSN's potential to beat the market
- SLSN doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
B
SLSN
RankedUnranked of 21
RankedUnranked of 21
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $68.99 | A | |
| $30.24 | A | |
| $86.96 | B |
Be the first to know about important SLSN news, forecast changes, insider trades & much more!
SLSN News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SLSN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SLSN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SLSN is good value based on its book value relative to its share price (4.6x), compared to the US Household & Personal Products industry average (7.2x)
P/B vs Industry Valuation
SLSN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SLSN due diligence checks available for Premium users.
Valuation
SLSN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-42.8x
Industry
27.09x
Market
44.91x
SLSN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.6x
Industry
7.2x
SLSN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SLSN's financial health
Profit margin
Revenue
$15.3M
Net Income
-$158.0k
Profit Margin
-1%
SLSN's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SLSN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$46.4M
Liabilities
$33.3M
Debt to equity
2.53
SLSN's short-term liabilities ($26.01M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SLSN's short-term assets ($25.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SLSN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SLSN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$191.0k
Investing
-$469.0k
Financing
$751.0k
SLSN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SLSN vs Household & Personal Product Stocks
Solesence Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.